Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 23 hours 4 min ago
Lilly Takes More Legal Actions Over Compounded Tirzepatide, Warns About Counterfeits
Lilly Takes More Legal Actions Over Compounded Tirzepatide, Warns About Counterfeits 6/20/2024
Gilead’s Twice-Yearly Shot Shows 100% Efficacy in Phase III HIV Prevention Trial in Women
Gilead’s Twice-Yearly Shot Shows 100% Efficacy in Phase III HIV Prevention Trial in Women 6/20/2024
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold 6/20/2024
Challenging Research Models to Improve Health Equity
Challenging Research Models to Improve Health Equity 6/20/2024
Experimental Parkinson’s Treatment Elicits Antibodies Against Toxic Protein in Phase I
Experimental Parkinson’s Treatment Elicits Antibodies Against Toxic Protein in Phase I 6/20/2024
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap 6/20/2024
Executives Share Top Tips for a Successful Career Journey
Executives Share Top Tips for a Successful Career Journey 6/20/2024
Better Collaboration: 7 Tips for Effective Workplace Communication
Better Collaboration: 7 Tips for Effective Workplace Communication 6/20/2024
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight
FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight 6/20/2024
NIH Finds Non-Chemo Drug Combo Induces Lasting Remission in DLBCL Patients
NIH Finds Non-Chemo Drug Combo Induces Lasting Remission in DLBCL Patients 6/20/2024
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study 6/20/2024
BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More
BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More 6/18/2024
Zentalis Hit With FDA Partial Clinical Hold on Cancer Studies After Patient Deaths
Zentalis Hit With FDA Partial Clinical Hold on Cancer Studies After Patient Deaths 6/18/2024
AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial
AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial 6/18/2024
Merck Wins FDA Approval for First Pneumococcal Vaccine Designed for Adults
Merck Wins FDA Approval for First Pneumococcal Vaccine Designed for Adults 6/18/2024
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies
GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies 6/18/2024
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies
Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies 6/18/2024
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up
Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up 6/18/2024
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’
FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’ 6/17/2024
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures 6/17/2024
World Pharma News
- Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
- Study shows ancient viruses fuel modern-day cancers
- Darolutamide meets primary endpoint in Phase III ARANOTE trial
- Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron
- New AI approach optimizes antibody drugs